Publications of Agnes J. Szczepek
All genres
Journal Article (11)
1.
Journal Article
283 (10), pp. 6438 - 6448 (2008)
Reduced display of tumor necrosis factor receptor I at the host cell surface supports infection with Chlamydia trachomatis. Journal of Biological Chemistry 2.
Journal Article
8 (10), pp. 1643 - 1655 (2006)
NF-kappa B and inhibitor of apoptosis proteins are required for apoptosis resistance of epithelial cells persistently infected with Chlamydophila pneumoniae. Cellular Microbiology 3.
Journal Article
74 (1), pp. 77 - 83 (2005)
Detection of Chlamydophila pneumoniae in the bone marrow of two patients with unexplained chronic anaemia. European Journal of Haematology 4.
Journal Article
4 (10), pp. 2969 - 2981 (2004)
Action and reaction: Chlamydophila pneumoniae proteome alteration in a persistent infection induced by iron deficiency. Proteomics 5.
Journal Article
51 (2), pp. 319 - 334 (2004)
From the inside out - processing of the Chlamydial autotransporter PmpD and its role in bacterial adhesion and activation of human host cells. Molecular Microbiology 6.
Journal Article
17 (7), pp. 1384 - 1389 (2003)
A cholesterol-dependent CD20 epitope detected by the FMC7 antibody. Leukemia 7.
Journal Article
5 (5), pp. 315 - 322 (2003)
Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae. Cellular Microbiology 8.
Journal Article
69 (12), pp. 7880 - 7888 (2001)
Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis. Infection and Immunity 9.
Journal Article
3 (6), pp. 427 - 437 (2001)
Low iron availability modulates the course of Chlamydia pneumoniae infection. Cellular Microbiology 10.
Journal Article
3 (6), pp. 427 - 437 (2001)
Low iron availability modulates the course of Chlamydia pneumoniae infection. Cellular Microbiology 11.
Journal Article
46 (2), pp. 98 - 104 (2001)
Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: Evidence from phenotyping after rituxan therapy and transfectant cell analyses. Cytometry